edotreotide has been researched along with Kidney Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fabritius, MP; Mansour, N; Rangan, K; Rübenthaler, J; Tiling, R | 1 |
| Bodei, L; Chinol, M; Cremonesi, M; Paganelli, G | 1 |
| Boerman, OC; Corstens, FH; Oyen, WJ | 1 |
3 other study(ies) available for edotreotide and Kidney Neoplasms
| Article | Year |
|---|---|
68 Ga-DOTATOC PET/CT in Pancreatic Metastasis From Clear Cell Renal Cell Carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2023 |
Facts and myths about radiopeptide therapy: Scylla, Charybdis and Sibyl.
Topics: Humans; Indium Radioisotopes; Kidney Neoplasms; Octreotide; Radiotherapy Dosage | 2002 |
Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney.
Topics: Humans; Indium Radioisotopes; Kidney Neoplasms; Octreotide; Radiotherapy Dosage | 2001 |